Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Maximizing post-merger success with strategic compliance
Mergers and acquisitions (M&A) can create significant value, but they also present inherent risks that organizations should recognize and address. Post-merger...